Henrik Stage joined Ventac Partners in March 2015. He has more than 25 years of executive experience in biotech and finance.
Henrik has previously served as CFO and CEO of Santaris Pharma A/S, Denmark. Established in 2000, Santaris Pharma was sold to Hoffmann-La Roche in 2014 for 450m USD in up-fronts and earn-outs. Now continuing business under the name Roche Innovation Centre Copenhagen.
Leading up to the sale to Roche Henrik led the preparation of Santaris for a Q3 2014 IPO at NASDAQ in USA.
As part of the executive management team for more than a decade, Henrik transformed Santaris from a “technology platform company” to a “clinical stage company” with a diverse pipeline of 6 drugs. During this time the following key milestones were achieved: 1) Raised +150m USD in dilutive funds from venture capital investors and 2) +150m USD in non-dilutive funds from pharma partners in 10 out-licensing deals with an overall value in excess of 3 billion USD.
Prior to joining the executive management team of Santaris Pharma Henrik held senior executive positions at Carlsberg, FL Smidth, Hempel and Hardi. He has lived and worked in the USA, Canada and Vietnam.
Henrik earned his MSc. from Copenhagen Business School.